Bioequivalence and Bioavailability Forum • Drug-drug interaction with two different route of administration

Drug-drug interaction with two different route of administration [Design Issues]

posted by dshah – India, 2022-07-21 20:51 (1029 d 10:38 ago) – Posting: # 23156
Views: 3,523

Dear Rao!
Kindly see the below articles which might help you.

No relevant pharmacokinetic drug-drug interaction between nintedanib and pirfenidone. Eur Respir J . 2019 Jan 10;53(1):1801060. doi: 10.1183/13993003.01060-2018.
Pharmacological Interactions of Nintedanib and Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis in Times of COVID-19 Pandemic. Pharmaceuticals (Basel). 2021 Aug; 14(8): 819.
Clinical biopharmaceutics review.

They might help you to proceed further.

Regards,
Divyen Shah

Complete thread:

Drug-drug interaction with two different route of administration Mr.Rao 2022-07-13 13:51 [Design Issues]
- Drug-drug interaction with two different route of administration Mr.Rao 2022-07-14 09:05
  - Drug-drug interaction with two different route of administration dshah 2022-07-20 10:27
    - Drug-drug interaction with two different route of administration Mr.Rao 2022-07-21 11:24
      - Drug-drug interaction with two different route of administrationdshah 2022-07-21 18:51
        
        Drug-drug interaction with two different route of administration Mr.Rao 2022-07-22 07:23
        
        Drug-drug interaction with two different route of administration Mr.Rao 2022-07-27 08:31
        
        Interpreting results of a DDI study Helmut 2022-07-27 09:52

Admin contact
23,424 posts in 4,927 threads, 1,672 registered users;
200 visitors (0 registered, 200 guests [including 8 identified bots]).
Forum time: 07:30 CEST (Europe/Vienna)

A statistical analysis, properly conducted, is a delicate dissection of
uncertainties, a surgery of suppositions. Micheal J. Moroney

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC

Ing. Helmut Schütz